Disease Mongering (Pseudo-Disease Promotion)
In-Depth Analysis
15-11-2012
Disease mongering is the promotion of pseudo-diseases by the pharmaceutical industry aiming at economic benefit. Medical equipment manufacturers, insurance companies, doctors or patient groups may also use it for monetary gain or influence. It has increased in parallel with society's 'medicalisation' and the growth of the pharmaceutical complex. Due to massive investments in marketing and lobbying, ample use of internet and media, and the emergence of new markets, it is becoming a matter of concern, and policy makers should be aware of its perils and consequences.
In-Depth Analysis
About this document
Publication type
Policy area
Keyword
- conflict of interest
- consumer protection
- consumption
- disease prevention
- EMPLOYMENT AND WORKING CONDITIONS
- EU institutions and European civil service
- European Medicines Agency
- EUROPEAN UNION
- health
- health service
- labour law and labour relations
- pharmaceutical industry
- pharmaceutical product
- public health
- SOCIAL QUESTIONS
- TRADE